In an attempt to resolve part of this gap, Pregnolato et al. [10] developed the EUREKA algorithm, including the low aPL titers, which means that those women who were excluded from the diagnostic of APS, and therefore, without treatment, will be considered. This evidence concerns the gene FASLG and autoimmune polyendocrinopathy.